Luteal Phase Commencing of Growth Hormone

This study has been completed.
Ren-Tıp ART Center, Bursa, Turkey
Information provided by:
Gulhane School of Medicine Identifier:
First received: November 19, 2007
Last updated: November 20, 2007
Last verified: November 2007

Commencing of growth hormone in luteal phase when follicular cohort for the next cycle is being gathered may increase mature oocytes in poor responder

Condition Intervention Phase
Drug: Norditropin pen
Phase 4

Study Type: Observational
Study Design: Observational Model: Case Control
Time Perspective: Prospective
Official Title: Growth Hormone co-Treatment Within a GnRH Agonist Long Protocol in Patients With Poor Ovarian Response

Resource links provided by NLM:

Further study details as provided by Gulhane School of Medicine:

Primary Outcome Measures:
  • mature oocyte number [ Time Frame: 2 years ]

Secondary Outcome Measures:
  • pregnancy rate [ Time Frame: 2 years ]

Enrollment: 61
Study Start Date: January 2005
Study Completion Date: November 2007
Groups/Cohorts Assigned Interventions
poor responder
Drug: Norditropin pen
12 IU per day


Ages Eligible for Study:   20 Years to 40 Years
Genders Eligible for Study:   Female
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

poor response to previous COH in the same center


Inclusion Criteria:

  • Poor responder

Exclusion Criteria:

  • FSH >20 IU
  Contacts and Locations
Please refer to this study by its identifier: NCT00561769

Ren Tıp ART Center
Bursa, Turkey, 16200
Sponsors and Collaborators
Gulhane School of Medicine
Ren-Tıp ART Center, Bursa, Turkey
Study Director: Tansu Kucuk, Assoc Prof GATA Ankara
  More Information

No publications provided Identifier: NCT00561769     History of Changes
Other Study ID Numbers: GATA 2005-21
Study First Received: November 19, 2007
Last Updated: November 20, 2007
Health Authority: Turkey: Ministry of Health

Keywords provided by Gulhane School of Medicine:
poor responder
growth hormone

Additional relevant MeSH terms:
Genital Diseases, Male
Genital Diseases, Female
Hormones, Hormone Substitutes, and Hormone Antagonists
Physiological Effects of Drugs
Pharmacologic Actions processed this record on April 17, 2014